Prediction models for insulin resistance in the polycystic ovary syndrome

Human Reproduction

Volumn 15, Issue 10, 2000, Pages 2098-2102

  Gennarelli, G ^a,b   Holte, J ^a   Berglund, L ^a   Berne, C ^a   Massobrio, M ^b   Lithell, H ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Euglycaemic hyperinsulinaemic clamp; Insulin resistance; PCOS; Screening

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; C PEPTIDE; CHOLESTEROL; FATTY ACID; FOLLITROPIN; GLUCOSE; GONADOTROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING PROTEIN; TRIACYLGLYCEROL;

ADULT; AGING; ANTHROPOMETRY; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE CLAMP TECHNIQUE; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; METABOLIC DISORDER; OVARY POLYCYSTIC DISEASE; PREDICTION; REGRESSION ANALYSIS; SCREENING TEST; SKINFOLD;

EID: 0033780952     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.10.2098     Document Type: Article

References (44)

1. Relationships of generalized and regional adiposity to insulin sensitivity in men
2. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism
3. Prediction models for insulin resistance
4. Assessment of insulin sensitivity in vivo
5. Abdominal obesity and risk
6. Visceral obesity. A 'civilization syndrome'
7. Genetic and nongenetic determinants of regional fat distribution
8. Genetic determinants of regional fat distribution
9. Insulin and polycystic ovary syndrome: A new look at an old subject
10. Heterogeneity in beta-cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome
11. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
12. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women
13. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones
14. Insulin resistance: A multifaced syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
15. Glucose clamp technique: A method for quantifying insulin secretion and resistance
16. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia
17. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
18. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years
19. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
20. Insulin resistance and hypersecretion in obesity
21. Insulin resistance and lipid metabolism
22. Waist circumference predicts intra-abdominal fat better than waist:hip ratio in women
23. The association of girth measurements with disease in 32 856 women
24. Hirsutism: Implications, etiology, and management
25. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome
26. Polycystic ovary syndrome and insulin resistance: Thrifty genes struggling with over-feeding and sedentary life style?
27. Enhanced insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance
28. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: Relation to anthropometric, endocrine and metabolic variables
29. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome
30. Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: A sign of a pre-hypertensive state?
31. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance
32. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome
33. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
34. Insulin sensitivity and serum triglyceride level in obese white and black women: Relationship to visceral and truncal subcutaneous fat
35. Insulin sensitivity indices obtained from oral glucose tolerance testing
36. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
37. Insulin resistance - Mechanisms, syndromes, and implications
38. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome
39. The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women
40. Insulin resistance is a characteristic feature of primary hypertension independent of obesity
41. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women
42. Pathophysiology of insulin resistance in human disease
43. Interval estimates for correlation coefficients for within-person variation: Implication for study design and hypothesis testing
44. Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women